Cough syrup deaths: Tamil Nadu-based firm’s licence revoked, company shut down
Sresan Pharmaceutical company's owner, Ranganathan, was recently arrested by a special investigation team from Madhya Pradesh
Sresan Pharma owner, S Ranganathan, escorted by police to a local court after one of their medicines, Coldrif cough syrup, was linked to the death of multiple children in Madhya Pradesh, October, 10, 2025. Reuters
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Advertisement
The manufacturing licence of Tamil Nadu based Sresan Pharmaceutical company involved in making the adulterated cough syrup Coldrif has completely been revoked, and the company has been ordered to shut down, the state government informed on Monday.
The state Drug Control Department officials had during an inspection found the cough syrup contained 48.6 per cent of Diethylene Glycol (DEG), a toxic substance. This medicine is linked to the death of children in Madhya Pradesh.
Advertisement
Related news: Cough syrup deaths: ED raids Coldrif manufacturer, Tamil Nadu FDA officials
The officials had also found that the company lacked proper good manufacturing practices (GMP) and good laboratory practices (GLP), and they recorded over 300 critical and major violations.
The company's owner, G Ranganathan, was recently arrested by a special investigation team from Madhya Pradesh.
Advertisement
Earlier in the day, a team from the Enforcement Directorate raided the premises of Sresan Pharmaceuticals and some officials, in a Prevention of Money Laundering Act (PMLA) case.
“The drug manufacturing license of Sresan Pharmaceuticals has been completely cancelled, and the company has been closed. Orders have been given to conduct a detailed inspection of other drug manufacturing companies located in Tamil Nadu,” the government said in a release here.
Advertisement
Advertisement